Guangdong Taienkang Pharmaceutical Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 6.08%

Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has an Asset Resilience Ratio of 6.08% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 301263 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥150.03 Million

≈ $21.95 Million USD Cash + Short-term Investments

Total Assets

CN¥2.47 Billion

≈ $360.88 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how Guangdong Taienkang Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. See Guangdong Taienkang Pharmaceutical Co. L balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Taienkang Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Guangdong Taienkang Pharmaceutical Co. L worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥150.03 Million	6.08%
Total Liquid Assets	CN¥150.03 Million	6.08%

Asset Resilience Insights

Limited Liquidity: Guangdong Taienkang Pharmaceutical Co. Ltd maintains only 6.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Taienkang Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Taienkang Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd (2022–2025)

The table below shows the annual Asset Resilience Ratio data for Guangdong Taienkang Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.66%	CN¥40.20 Million ≈ $5.88 Million	CN¥2.42 Billion ≈ $353.72 Million	-3.62pp
2024-12-31	5.28%	CN¥122.10 Million ≈ $17.87 Million	CN¥2.31 Billion ≈ $338.18 Million	-6.01pp
2023-12-31	11.30%	CN¥251.80 Million ≈ $36.85 Million	CN¥2.23 Billion ≈ $326.19 Million	-0.50pp
2022-12-31	11.80%	CN¥240.65 Million ≈ $35.21 Million	CN¥2.04 Billion ≈ $298.46 Million	--

pp = percentage points

About Guangdong Taienkang Pharmaceutical Co. Ltd

SHE:301263 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.51 Billion

CN¥10.35 Billion CNY

Market Cap Rank

#7335 Global

#1690 in China

Share Price

CN¥20.27

Change (1 day)

+4.59%

52-Week Range

CN¥18.50 - CN¥41.40

All Time High

CN¥41.40